JUDE HALL: Open Payments
NPI 1013574425 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,061 in 141 payments from 29 companies in 2025. Trend: 2023 $1,827 · 2024 $2,796 · 2025 $3,061
Food & beverage: $3,061
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $518 |
| GlaxoSmithKline, LLC. | 16 | $341 |
| Novo Nordisk Inc | 11 | $294 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $211 |
| Neurocrine BioSciences, Inc. | 3 | $172 |
| Lilly USA, LLC | 12 | $167 |
| Abbott Laboratories | 7 | $165 |
| PFIZER INC. | 7 | $162 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Merck Sharp & Dohme LLC | 4 | $92 |
Products named: TRELEGY ELLIPTA, JARDIANCE, ELIQUIS, BREZTRI, INGREZZA, FREESTYLE LIBRE 3, FARXIGA, AIRSUPRA.
Industry payments across CT — which companies pay providers there.
